Saturday, September 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleNasdaq· April 9, 2026

Bitcoin's Scariest Risk Just Became More Likely to Happen. Should You Sell It?

View original at nasdaq.com
Bitcoin's Scariest Risk Just Became More Likely to Happen. Should You Sell It? Key Points Bitcoin is secured by encryption. That encryption is thought to be very burdensome to break with normal computers…
Opening lines of the source · Nasdaq · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Protocol upgrades will almost certainly arrive before any quantum machine can exploit the vulnerability for long-term investors

    60% confidence
  • A full migration to quantum-resistant cryptography for Bitcoin could take about seven years

    60% confidence
  • The encryption-breaking risk posed by quantum computers wouldn't pose an actual threat for approximately 10 years (prior to Google's new research)

    60% confidence
  • If you need the money within five years, this new paper is a reason to temper your Bitcoin allocation

    60% confidence
  • Stock Advisor's total average return is 946% compared to 190% for the S&P 500

    60% confidence
  • Bitcoin was not identified as one of the 10 best stocks for investors to buy now

    60% confidence
  • The quantum threat window just shrank from a comfortable decade to perhaps five to seven years

    60% confidence
  • Bitcoin's encryption can be cracked within minutes by an optimized quantum computer that needs 20X fewer physical qubits than prior estimates

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com